RhumbLine Advisers
DRTX

RhumbLine Advisers’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

RhumbLine Advisers’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-12,695
Closed -$161K – 3042
2014
Q3 		$161K Hold
12,695
– – ﹤0.01% 2832
2014
Q2 		$216K Buy
12,695
+1,088
+9% +$16.2K ﹤0.01% 2790
2014
Q1 		$156K Sell
11,607
-640
-5% -$8.38K ﹤0.01% 2849
2013
Q4 		$157K Hold
12,247
– – ﹤0.01% 2889
2013
Q3 		$111K Sell
12,247
-134
-1% -$1.11K ﹤0.01% 2921
2013
Q2 		$89K Buy
+12,381
New +$90.9K ﹤0.01% 3261

RhumbLine Advisers's DRTX Position: Q4 2014 in Review

RhumbLine Advisers sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 12,695 shares — an estimated $161K sold.

RhumbLine Advisers first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $216K in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • RhumbLine Advisers reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • RhumbLine Advisers sold 12,695 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $161K.
  • RhumbLine Advisers first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • RhumbLine Advisers's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $216K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on RhumbLine Advisers's 13F filing for Q4 2014, filed 6 Feb 2015.